Trials / Completed
CompletedNCT06506773
Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)
A Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis Less Than 12 Months of Age
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the natural history of exocrine pancreatic function by assessing Fecal elastase-1 (FE-1) in infants with CF during their first year of life.
Conditions
Timeline
- Start date
- 2024-07-09
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
- First posted
- 2024-07-17
- Last updated
- 2025-12-31
Locations
50 sites across 11 countries: United States, Australia, Canada, Czechia, Germany, Italy, New Zealand, Poland, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT06506773. Inclusion in this directory is not an endorsement.